Position in NVS
as of Jun 30, 2026
· filed Jul 16, 2026
Position Value
$235,080
+$5,955 QoQ
Shares Held
1,500
0.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.81%
of 13F equity value
Holder Rank
#1,246
of 1,603 holders
Holding Since
Dec 2025
3 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in NVS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026REBALANCE, LLC holds $1,260,922 across 3 Drug Manufacturers - General names. NVS ranks #3 (18.6% of the industry book) .
All Filings in NVS
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $235,080 | 1,500 | Shares | Sole | 2026-07-16 | |
| 2026-03-31 | $229,125 | 1,500 | Shares | Sole | 2026-05-11 | |
| 2025-12-31 | $206,805 | 1,500 | Shares | Sole | 2026-01-15 | |
| No filing history on record for this holder in this stock. | ||||||